Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

Clinical trial NCT01063803 · COMPLETED

Trial details

NCT number: NCT01063803
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2010-02-01
Primary completion: 2012-02-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.